[1] Durand P Y.Iron therapy: is it different with peritoneal dialysis compared to haemodialysis?. Nephrol Ther, 2006, 2 Suppl 5: 341-346.
[2] Wallace D F, Dixon J L, Ramm G A, et al. A novel mutation in ferroportin implicated in iron overload. Journal of Hepatology, 2007, 46(5): 921-926.
[3] Atanasiu V, Manolescu B, Stoian I. Hepcidin--central regulator of iron metabolism. Eur J Haematol, 2007, 78(1): 1-10.
[4] Chaudhuri S, Banerjee A, Basu K, et al. Interaction of flavonoids with red blood cell membrane lipids and proteins: Antioxidant and antihemolytic effects. International Journal of Biological Macromolecules, 2007, 41(1): 42-48.
[5] Ji D, Lv W, Huang Z, et al. Fluorescence resonance energy transfer imaging of CFP/YFP labeled NDH in cyanobacterium cell.Journal of Luminescence, 2007, 122-123(2007): 463-466.
[6] Chirio-lebrun M C, Prats M. Fluorescence resonance energy transfer (FRET): theory and experiments. Biochemical Education, 1998, 26(4): 320-323.
[7] Slimane T A, Fontanges P, Trugnan G. GFP, FRAP, FLIP, FRET, PRIM, FLASH ect.New microscopic techniques using new fluorescent probes. An overview. Biology of the Cell, 1999, 91(3): 227-228.
[8] Munishkina L A, Fink A L. Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins. Biochimica Biophys Acta,2007,1768(8):1862-1885.
[9] Theodorsson E. Haemochromatosis, hepcidin and disorders of iron metabolism: fields of substantial clinical relevance and current advances.. Scand J Clin Lab Invest, 2006, 66(2): 79-82.
[10] Chen Y, O’Donoghue M B, Huang Y F, et al. A surface energy transfer nanoruler for measuring binding site distances on live cell surfaces. Journal of American Chemical Society,2010,132(46):16559-16570.
|